SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Corona Remedies informs about AGM proceedings

10 Jul 2026 Evaluate
Corona Remedies has informed that Annual General Meeting (AGM) of the Company was held on Thursday, July 09, 2026 through Video Conferencing / Other Audio Visual Means. The following resolutions as mentioned in the Notice of the 22nd AGM were passed through remote e-voting: To receive, consider and adopt the Audited Financial Statements (Standalone and Consolidated) of the Company for the financial year ended March 31, 2026 and the Reports of the Board of Directors and Auditors thereon for the financial year ended March 31, 2026; To declare final dividend of ?10 each (Rupees Ten each) (100%) per Equity Share having face value of ?10 each for the FY2025-26; To appoint a Director in place of Nirav Mehta (DIN: 01644041), who retires by rotation and being eligible, offers himself for re-appointment;. To appoint Walker Chandiok & Co LLP, Chartered Accountants, as the Statutory Auditors of the Company and to fix their remuneration; To ratify the remuneration payable to the Cost Auditors for the FY2026-27; To appoint Dhara Patel, Company Secretary Firm as Secretarial Auditors of the Company; To approve payment of commission to the Non Executive Directors of the Company; To approve payment of remuneration to Dr. Kirtikumar Mehta (DIN: 00385658), Non Executive Director and Chairman of the Company for the Financial Year 2026-27; Re-appointment of Dr. Kirtikumar Mehta (DIN: 00385658) as Non Executive Director and Chairman of the Company for a term of 5 years.

The above information is a part of company’s filings submitted to BSE.

CORONA Remedies Share Price

2105.45 36.50 (1.76%)
29-Jul-2026 15:03 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1988.80
Dr. Reddys Labs. 1145.20
Cipla 1477.00
Lupin 2450.60
Zydus Lifesciences 1122.95
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: